Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Cyclo Therapeutics Inc (CYTH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cyclo Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.23 -0.04    -1.76%
08/08 - Closed. Currency in USD ( Disclaimer )
After Hours
2.10
-0.13
-5.83%
17:29:18 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 30,257
  • Bid/Ask: 2.10 / 2.24
  • Day's Range: 2.16 - 2.46
Cyclo Therapeutics 2.23 -0.04 -1.76%
IndustryBiotechnology
SectorHealthcare
Employees

8

Equity Type

ORD

Cyclo Therapeutics, Inc. is a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company's lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin) is for the treatment of Niemann-Pick Type C disease (NPC). NPC is a rare and fatal cholesterol metabolism disease that impacts the brain, lungs, liver, spleen, and other organs. It is also focusing on the use of cyclodextrins in the treatment of Alzheimer's disease. The Company's product lines include Trappsol and Aquaplex. It sells its chemical products directly to customers in the pharmaceutical, diagnostics, and industrial chemical industries, and to chemical supply distributors. The Company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Contact Information

Top Executives

Name Age Since Title
F. Patrick Ostronic 65 2014 Independent Vice Chairman
Randall M. Toig 70 2018 Independent Director
Markus Walter Sieger 55 2014 Independent Chairman
N. Scott Fine 64 2014 CEO & Director
Benny Liu - 2015 Member of Scientific Advisory Board
Gerald F. Cox 62 2021 Member of Scientific Advisory Board
Caroline Hastings - 2015 Member of Scientific Advisory Board
William S. Shanahan 82 2016 Independent Director
Rita R. Colwell - - Co-Chair of Scientific Advisory Board
Sharon H. Hrynkow 62 2014 Co-Chairman of Scientific Advisory Board
C. E Strattan 76 1990 Founder & Director
Jeffrey L. Tate 64 2010 COO, Chief Quality Officer & Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CYTH Comments

Write your thoughts about Cyclo Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carl Stonks
Carl Stonks Sep 13, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why going down?
colin goostree
colin goostree May 21, 2021 10:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hopefully this goes the way of ANVS
michael radey
michael radey Feb 19, 2021 8:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well this took a hit - comeback time
per haps
perhaps Feb 04, 2021 4:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2022 go To 90$
michael radey
michael radey Feb 04, 2021 4:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why even comment something like this...?
per haps
perhaps Feb 04, 2021 4:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
michael radey  2014 $105....2018... $118.  2022 $90 sure???
michael radey
michael radey Feb 04, 2021 1:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy buy buy
michael radey
michael radey Feb 04, 2021 1:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MOOOOON 🚀
michael radey
michael radey Feb 04, 2021 9:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
LETS GOOO
michael radey
michael radey Jan 15, 2021 8:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Break 5.55 and we’ll have ourselves a runner!
michael radey
michael radey Jan 05, 2021 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats the deal here people? This gonna moon!?
nikko legaspi
nikko legaspi Jan 04, 2021 4:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
14+
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email